• Abuhammad AM, Lowe ED, Fullam E, Noble M, Garman EF, Sim E (2010). Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active site. Protein Cell 1: 384392.
  • Kubiak X, Pluvinage B, Li de la Sierra-Gallay I, Weber P, Haouz A, Dupret JM et al. (2012). Purification, crystallization and preliminary X-ray characterization of Bacillus cereus arylamine N-acetyltransferase 3 [(BACCR)NAT3]. Acta Crystallogr Sect F Struct Biol Cryst Commun 68 (Pt 2): 196198.
  • Martins M, Pluvinage B, de la Sierra-Gallay IL, Barbault F, Dairou J, Dupret JM et al. (2008). Functional and structural characterization of the arylamine N-acetyltransferase from the opportunistic pathogen Nocardia farcinica. J Mol Biol 383: 549560.
  • Pluvinage B, Li de la Sierra-Gallay I, Kubiak X, Xu X, Dairou J, Dupret JM et al. (2011). The Bacillus anthracis arylamine N-acetyltransferase ((BACAN)NAT1) that inactivates sulfamethoxazole, reveals unusual structural features compared with the other NAT isoenzymes. FEBS Lett 585: 39473952.
  • Sikora AL, Frankel BA, Blanchard JS (2008). Kinetic and chemical mechanism of arylamine N-acetyltransferase from Mycobacterium tuberculosis. Biochemistry 47: 1078110789.
  • Sim E, Fakis G, Laurieri N, Boukouvala S (2012). Arylamine N-acetyltransferases – from drug metabolism and pharmacogenetics to identification of novel targets for pharmacological intervention. Adv Pharmacol 63: 169205.
  • Wang H, Vath GM, Gleason KJ, Hanna PE, Wagner CR (2004). Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis and pre-steady state and steady state kinetic studies. Biochemistry 43: 82348246.
  • Wang H, Liu L, Hanna PE, Wagner CR (2005). Catalytic mechanism of hamster arylamine N-acetyltransferase 2. Biochemistry 44: 1129511306.
  • Zhou X, Ma Z, Dong D, Wu B (2013). Arylamine N-acetyltransferases: a structural perspective. Br J Pharmacol 169: 748760.